We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Expanding Use of Quicker TAVI Procedure for AS Could Clear Heart Surgery Backlog

By HospiMedica International staff writers
Posted on 20 Jun 2022
Print article
Image: Heart surgery backlog requires urgent action, according to new research (Photo courtesy of Pexels)
Image: Heart surgery backlog requires urgent action, according to new research (Photo courtesy of Pexels)

Aortic stenosis (AS) develops when the heart’s aortic valve becomes narrowed, restricting blood flow out of the heart. The traditional treatment for AS involves replacing the narrowed valve, most commonly through open-heart surgery (a surgical aortic valve replacement, SAVR). But transcatheter aortic valve implantation (TAVI), which is a newer keyhole procedure, is increasingly being used and is now recommended for patients aged 75 and over. Prompt treatment is vital for people diagnosed with severe AS, as about 50% will die within two years of the symptoms beginning. However, the COVID-19 pandemic has led to thousands of heart procedures being postponed, and to record waiting lists. Now, an international team of researchers has found that converting a proportion of procedures from SAVR to TAVI would help clear the heart surgery backlog.

Researchers at the University of Leeds (West Yorkshire, UK) have warned that lack of action could result in thousands of people dying while waiting for treatment for AS and urgent action is needed to clear the backlog of people waiting for life-saving treatment. Previous work has estimated that 4,989 people in the UK with severe AS missed out on life-saving treatment between March and November 2020. The researchers modeled the potential impact on waiting lists of increased treatment capacity as well as the use of the quicker, less invasive TAVI procedure. Even in the best-case scenario, they found that the waiting list would take nearly a year to clear and more than 700 people would die while waiting for treatment.

The researchers investigated the impact that increasing treatment capacity and converting a proportion of operations to the quicker TAVI procedure would have on the backlog. They found that the best and most achievable option involved a combination of increasing capacity by 20% and converting 40% of procedures from SAVR to TAVI. This would clear the backlog within 343 days, with 784 deaths while people wait for treatment. The team wants to see greater collaboration at local and national levels to agree the changes needed that can ensure that people with severe AS receive crucial treatment as quickly as possible.

“During the COVID-19 pandemic, there was a great decline in procedures used to treat severe aortic stenosis. In our study, we found that without a combination of increased capacity for treatment of patients with severe AS and an expansion in the use of TAVI, there would be many potentially avoidable deaths during the post-COVID-19 recovery period,” said Professor Chris Gale, a Professor of Cardiovascular Medicine at the School of Medicine and Co-Director of Leeds Institute for Data Analytics. “This is the only option that will prevent the death of thousands of people who have untreated aortic stenosis.”

“Before the pandemic around 13,500 SAVR and TAVI procedures were performed each year across the UK. Increasing capacity by 20% would represent one or two additional TAVI procedures each week per centre,” added Professor Mamas Mamas, Professor of Cardiology at Keele University and consultant cardiologist at University Hospitals of North Midlands NHS Trust, who was one of the study’s lead researchers.

Related Links:
University of Leeds 

Platinum Supplier
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Supplier
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Cryosurgery Unit
Extracorporeal Shock Wave Therapy Device
Aries 2

Print article


Surgical Techniques

view channel
Image: Suppressing production of an immune protein could reduce rejection of biomedical implants (Photo courtesy of 123RF)

Protein Identified for Immune Rejection of Biomedical Implants to Pave Way for Bio-Integrative Medical Devices

Biomedical implants like breast implants, pacemakers, and orthopedic devices have revolutionized healthcare, yet a substantial number of these implants face rejection by the body and have to be removed.... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The broad-spectrum POC coagulometer is well-suited for emergency room and emergency vehicle use (Photo courtesy of Perosphere)

Novel POC Coagulometer with Lab-Like Precision to Revolutionize Coagulation Testing

In emergency settings, when patients arrive with a bleed or require urgent surgery, doctors rely solely on clinical judgment to determine if a patient is adequately anticoagulated for reversal treatment.... Read more


view channel
Image: The global surgical lights market is expected to grow by close to USD 0.50 billion from 2022 to 2027 (Photo courtesy of Freepik)

Global Surgical Lights Market Driven by Increasing Number of Procedures

The global surgical lights market is set to witness high growth, largely due to the increasing incidence of chronic illnesses, a surge in demand for cosmetic and plastic surgeries, and untapped opportunities... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.